Jane E Freedman. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Aspirin/pharmacologyAspirin/therapeutic useCoronary Artery Disease/bloodCoronary Artery Disease/drug therapyCoronary Artery Disease/prevention & controlCyclooxygenase 1/geneticsCyclooxygenase 1/physiologyCyclooxygenase 2/geneticsCyclooxygenase 2/physiologyDose-Response Relationship, DrugDrug ResistanceEnzyme Activation/drug effectsFemaleFlow CytometryHumansMalePlatelet Aggregation/drug effectsPlatelet Aggregation/geneticsPlatelet Aggregation Inhibitors/pharmacologyPlatelet Aggregation Inhibitors/therapeutic usePlatelet Function TestsPrevalenceRecurrenceThromboxane A2/bloodTime FactorsTreatment Refusal
Substances: See more » Platelet Aggregation InhibitorsThromboxane A2Cyclooxygenase 1Cyclooxygenase 2Aspirin
Year: 2006 PMID: 16801473 DOI: 10.1161/CIRCULATIONAHA.106.635847
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690